Talk:Rhizoxin
From Wikipedia, the free encyclopedia
 |
Rhizoxin is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project. | ||
| Stub | This article has been rated as Stub-Class on the wikiproject's quality scale. | ||
| Low | This article has been rated as Low-importance on the importance scale. | ||
|
Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need. |
|||
What is the state of rhizoxin as a drug? If its FDA/etc. approved then {{template:drugbox}} would be more appropriate than {{template:chembox}}. - Zephyris Talk 21:37, 5 March 2007 (UTC)
- As far as I know, and after a quick search, rhizoxin is investigational. The U.S. National Cancer Institute lists only Phase I trials, the most recent concluded nearly 9 years ago. However, if you think {{drugbox}} would be better, feel free to replace it! Fvasconcellos 22:08, 5 March 2007 (UTC)
- Just found out it stalled after phase II trials due to low activity in vivo - chembox therefore seems more appropriate. I may have broken some of the footnote fixes you made in extending the article (edit conflict) sorry! :( - Zephyris Talk 22:38, 5 March 2007 (UTC)
- No problem—fixing them again only takes a click :) Glad you managed to dig deeper than I did on the clinical trials. Fvasconcellos 23:43, 5 March 2007 (UTC)
- Just found out it stalled after phase II trials due to low activity in vivo - chembox therefore seems more appropriate. I may have broken some of the footnote fixes you made in extending the article (edit conflict) sorry! :( - Zephyris Talk 22:38, 5 March 2007 (UTC)
